Skip to Content

Terumo Announces Change of Directors and Executive Officers

Feb 04, 2021

TOKYO, JAPAN – February 4, 2021 – Terumo Corporation (TSE: 4543) today announced that it has resolved a change of its Directors and Executive Officers as follows.

1. Change of Director (As of April 1, 2021) 

Name New Title Current Title
Kyo Nishikawa

Director and Managing Executive Officer

Chief Human Resources Officer (CHRO) 

Director and Senior Executive Officer

Chief Human Resources Officer (CHRO) 


2. Change of Director (As of June 22, 2021)

Name New Title Current Title
Takanori Shibazaki

Director (Audit and Supervisory Committee Member)

Senior Executive Officer

Audit and Supervisory Committee Office

*Subject to the approval of the Annual General Meeting of Shareholders to be held on June 22, 2021.
*He will arrive at Audit and Supervisory Committee Office from the current position (Regional Representative, China) as of June 1, 2021.

3. Change of Executive Officers (As of April 1, 2021)

Name New Title Current Title
Fumihisa Hirose

Senior Executive Officer

General Manager, Strategic Planning Dept.

Chief Technology Officer (CTO)

Executive Officer

General Manager, Strategic Planning Dept.

Masayuki Maruta Executive Officer President and CEO, Terumo (China) Holdings Co., Ltd. Chairman, Terumo Medical (Shanghai) Co., Ltd.
Hiroshi Yagi

Executive Officer

Factory Manager, Ashitaka Factory, Interventional Systems Division, Cardiac and Vascular Company

Factory Manager, Ashitaka Factory, Interventional Systems Division, Cardiac and Vascular Company
Jin Nishizaki

Executive Officer

Branch Manager, Tokyo Branch, General Hospital Company

Branch Manager, Tokyo Branch, General Hospital Company


4. Change of Executive Officer (As of June 1, 2021)

Name New Title Current Title
Masayuki Maruta

Executive Officer

Regional Representative, China President and CEO, Terumo (China) Holdings Co., Ltd.

Executive Officer President and CEO, Terumo (China) Holdings Co., Ltd.

 

About Terumo

Terumo (TSE:4543) is a global leader in medical technology and has been committed to "Contributing to Society through Healthcare" for 100 years. Based in Tokyo and operating globally, Terumo employs more than 25,000 associates worldwide to provide innovative medical solutions in more than 160 countries and regions. The company started as a Japanese thermometer manufacturer, and has been supporting healthcare ever since. Now, its extensive business portfolio ranges from vascular intervention and cardio-surgical solutions, blood transfusion and cell therapy technologies, to medical products essential for daily clinical practice such as transfusion systems, diabetes care, and peritoneal dialysis treatments. Terumo will further strive to be of value to patients, medical professionals, and society at large.